Dr. Robert Kenneth Fairbanks, MD

Dr. Fairbanks practices at St. Joseph Regional Medical Center in Lewiston, Idaho, part of Lifepoint Health.

Dr. Fairbanks' NPI, 1821084781, was assigned on September 26, 2005. Dr. Fairbanks graduated from Tulane School of Medicine in 1992. Dr. Fairbanks holds Washington license MD00037655.

Dr. Fairbanks' primary practice is St. Joseph Regional Medical Center, at 415 Sixth Street, Lewiston, ID 83501 in Nez Perce County. The practice phone is (208) 799-5300.

Dr. Fairbanks' primary practice is St. Joseph Regional Medical Center in Lewiston, Idaho, part of Lifepoint Health. Dr. Fairbanks is also affiliated with Gritman Medical Center. The medical group on file is Cancer Care Northwest. Dmand AI also links Dr. Fairbanks to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fairbanks practices, 7 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Fairbanks' primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Fairbanks is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Fairbanks' licenses on file in 4 states: Washington, Idaho, Texas and Louisiana.

Dmand AI lists anal cancer radiation, bladder cancer radiation, bone cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, cervical cancer radiation and colorectal cancer radiation among the conditions Dr. Fairbanks treats.

CMS data shows 6,034 Medicare services from Dr. Fairbanks across 25 procedure codes in 2024, for 472 Medicare patients. Medicare paid $831,636 for them.

CMS counts 472 Medicare patients who saw Dr. Fairbanks in 2024. The largest group is 65 to 74, with 205 patients. 71% of them have high blood pressure, and 70% have cancer. 7% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fairbanks' median patient age at 74, with 37% women.

In 2024, Dr. Fairbanks wrote 279 Medicare Part D claims for 100 patients. 88% of them were for generic drugs. CMS names the drug for 187 of them, across 10 drugs with 11 or more claims each, at $4,159 in total drug cost. In 2023, CMS named 138 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Fairbanks for performance year 2024, reported as part of a group. Dr. Fairbanks accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Fairbanks, published from 2014 to 2020. Dr. Fairbanks' most frequent co-authors are Wayne Tenney Lamoreaux, MD, Christopher Melvin Lee, MD and Jonathan D. Carlson, MD.

CMS Open Payments shows 24 general payments to Dr. Fairbanks from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Elekta, Inc. paid the most, $806.

Dr. Fairbanks graduated from Tulane School of Medicine in 1992.

Dr. Fairbanks is in network with 12 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.